Table 1.
Reference | Patients | Disease | Daily dose* | No. of doses | Route | Symptomatic |
---|---|---|---|---|---|---|
Tvede et al.6 | 5 patients: 4 female (21-52 years) and 1 male (53 years) | Rheumatoid arthritis | 1250 mg | 2-3 | IV | 1 patient |
Guillén et al.7 | 73-year-old female | Pulmonary-renal syndrome | 375 mg | 1 | IV | Yes |
Küçükosmanoğlu et al.8 | 14-year-old male | Glomerulonephritis | 1875 mg | 1 | IV | Yes |
Pudil and Hrncir9 | 2 female (14-28 years) | Rheumatoid arthritis, polyarticular arthritis syndrome | 156.3 mg | 4-5 | IV | No |
Jain et al.10 | 10 patients: 9 female (29-58 years), 1 male (39 years) | Pemphigus vulgaris | 933.3 mg | 1 | IV | No |
Al Shibli et al.11 | 14-year-old female | Steroid-sensitive nephrotic syndrome | 80 mg | 7 | Oral | No |
Taylor and Gaco5 | 45-year-old female | Multiple sclerosis | 1250 mg | 5 | Oral | No |
Kundu and Fitzgibbons12 | 48-year-old female | Multiple sclerosis | 1250 mg | 4 | IV | Yes |
Domínguez-Pinilla et al.13 | 15-year-old male | Juvenile idiopathic arthritis | 312.5 mg | 3 | IV | No |
John et al.14 | 58-year-old male | Laryngeal edema | 50 mg | 2 | IV | Yes |
Beyan et al.15 | 2 patients: 1 female (24 years) and 1 male (25 years) | Behçet and LES | 1250 and 150 mg | 3-4 | IV | 1 patient |
Dashore et al.16 | 5 female patients (34-67 years) | Pemphigus vulgaris | 125 mg | 2-3 | IV | 2 patients |
Marinov et al.17 | 51-year-old female | Postoperative nausea and vomiting | 25 mg | 1 | IV | Yes |
Hasan and Al-Khazraji18 | 54-year-old female | Adrenal insufficiency | 100 mg | 1 | Oral | Yes |
Abbreviation: IV, intravenous.
steroids daily dose.